Lack of QT Prolongation for 2′-O-Methoxyethyl-Modified Antisense Oligonucleotides Based on Retrospective Exposure/Response Analysis of Ten Phase 1 Dose-Escalation Placebo-Controlled Studies in Healthy Subjects

The potential of QT prolongation of ten 2′-O-methoxyethyl-modified (2′-MOE) antisense oligonucleotides (ASOs) was evaluated retrospectively via exposure/response (ER) analysis using data from Phase 1 clinical studies in healthy subjects. All Phase 1 studies were double-blind, placebo-controlled, sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Rosie Z., Gunawan, Rudy, Geary, Richard S., Hughes, Steven G., Henry, Scott P., Wang, Yanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649121/
https://www.ncbi.nlm.nih.gov/pubmed/28799823
http://dx.doi.org/10.1089/nat.2017.0676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649121/
https://www.ncbi.nlm.nih.gov/pubmed/28799823
http://dx.doi.org/10.1089/nat.2017.0676

Ejemplares similares